{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:07:42Z","timestamp":1790755662548,"version":"4.1.0"},"reference-count":68,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1097\/cnd.0000000000000065","type":"journal-article","created":{"date-parts":[[2015,2,18]],"date-time":"2015-02-18T15:05:19Z","timestamp":1424271919000},"page":"131-140","source":"Crossref","is-referenced-by-count":24,"title":["Necrotizing Myopathies"],"prefix":"10.1097","volume":"16","author":[{"given":"Colin","family":"Quinn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnny S.","family":"Salameh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nizar","family":"Souayah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210126","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/mus.22279","article-title":". Necrotizing myopathy: Clinicoserologic associations.","volume":"45","author":"Ellis","year":"2012","journal-title":"Muscle Nerve"},{"key":"R2-3-20210126","first-page":"335","article-title":"Uber primare nichteitrige polymyositis.","volume":"120","author":"Kankeleit","year":"1916","journal-title":"Dtsch Arch Klin Med"},{"key":"R3-3-20210126","first-page":"207","article-title":"J Pathol.","volume":"97","year":"1969","journal-title":""},{"key":"R4-3-20210126","first-page":"398","article-title":"Necrosis of muscle with carcinoma: myositis or myopathy J Neurol Neurosurg Psychiatry.","volume":"33","author":"Urich","year":"1970","journal-title":""},{"key":"R5-3-20210126","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/BF00328515","article-title":". Paraneoplastic necrotizing myopathy: a rare disorder to be differentiated from polymyositis.","volume":"236","author":"Vosskamper","year":"1989","journal-title":"J Neurol"},{"key":"R6-3-20210126","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":". 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, the Netherlands.","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"R7-3-20210126","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1365-2990.2010.01153.x","article-title":"Review: an update on inflammatory and autoimmune myopathies.","volume":"37","author":"Dalakas","year":"2011","journal-title":"Neuropathol Appl Neurobiol"},{"key":"R8-3-20210126","doi-asserted-by":"crossref","first-page":"9507","DOI":"10.1073\/pnas.83.24.9507","article-title":"Human autoantibodies reactive with the signal-recognition particle.","volume":"83","author":"Reeves","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R9-3-20210126","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/art.11484","article-title":". Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy.","volume":"50","author":"Kao","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R10-3-20210126","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/art.27572","article-title":". A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy.","volume":"62","author":"Christopher-Stine","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R11-3-20210126","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","article-title":". A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups.","volume":"70","author":"Love","year":"1991","journal-title":"Medicine (Baltimore)"},{"key":"R12-3-20210126","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1212\/WNL.50.3.764","article-title":". Paraneoplastic necrotizing myopathy: clinical and pathological features.","volume":"50","author":"Levin","year":"1998","journal-title":"Neurology"},{"key":"R13-3-20210126","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2169\/internalmedicine.39.176","article-title":". Necrotizing myopathy in a patient with chronic hepatitis C virus infection: a case report and a review of the literature.","volume":"39","author":"Satoh","year":"2000","journal-title":"Intern Med"},{"key":"R14-3-20210126","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.410140404","article-title":". Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients.","volume":"14","author":"Snider","year":"1983","journal-title":"Ann Neurol"},{"key":"R15-3-20210126","doi-asserted-by":"crossref","first-page":"342","DOI":"10.7326\/0003-4819-114-4-342_1","article-title":"Rhabdomyolysis and simvastatin.","volume":"114","author":"Deslypere","year":"1991","journal-title":"Ann Intern Med"},{"key":"R16-3-20210126","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1056\/NEJM196810172791604","article-title":"Acute muscular syndrome associated with administration of clofibrate.","volume":"279","author":"Langer","year":"1968","journal-title":"N Engl J Med"},{"key":"R17-3-20210126","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/(SICI)1097-4598(199912)22:12<1631::AID-MUS3>3.0.CO;2-V","article-title":"Muscle disorders associated with cyclosporine treatment.","volume":"22","author":"Breil","year":"1999","journal-title":"Muscle Nerve"},{"key":"R18-3-20210126","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0887-8994(90)90122-H","article-title":". Reversible myopathy due to labetalol.","volume":"6","author":"Willis","year":"1990","journal-title":"Pediatr Neurol"},{"key":"R19-3-20210126","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1212\/WNL.50.1.301","article-title":"Rhabdomyolysis and hypoxia associated with prolonged propofol infusion in children.","volume":"50","author":"Hanna","year":"1998","journal-title":"Neurology"},{"key":"R20-3-20210126","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/096032719301200406","article-title":"Effects of organophosphates on skeletal muscle.","volume":"12","author":"Karalliedde","year":"1993","journal-title":"Hum Exp Toxicol"},{"key":"R21-3-20210126","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJM198902163200701","article-title":". The effects of alcoholism on skeletal and cardiac muscle.","volume":"320","author":"Urbano-Marquez","year":"1989","journal-title":"N Engl J Med"},{"key":"R22-3-20210126","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1001\/jama.1993.03510150080034","article-title":"Myositis-specific autoantibodies. Touchstones for understanding the inflammatory myopathies.","volume":"270","author":"Miller","year":"1993","journal-title":"JAMA"},{"key":"R23-3-20210126","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.4049\/jimmunol.138.10.3219","article-title":". Characterization of human autoantibodies that selectively precipitate the 7SL RNA component of the signal recognition particle.","volume":"138","author":"Okada","year":"1987","journal-title":"J Immunol"},{"key":"R24-3-20210126","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/art.1780330908","article-title":"Antibody to signal recognition particle in polymyositis.","volume":"33","author":"Targoff","year":"1990","journal-title":"Arthritis Rheum"},{"key":"R25-3-20210126","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/ard.60.2.116","article-title":". Autoantibody profiles in the sera of European patients with myositis.","volume":"60","author":"Brouwer","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"R26-3-20210126","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/jnnp.73.4.420","article-title":". Myopathy with antibodies to the signal recognition particle: clinical and pathological features.","volume":"73","author":"Miller","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R27-3-20210126","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1136\/ard.2006.052191","article-title":". Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy.","volume":"65","author":"Hengstman","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R28-3-20210126","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/acr.20219","article-title":". Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series.","volume":"62","author":"Valiyil","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R29-3-20210126","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/art.1780341108","article-title":". Distinct seasonal patterns in the onset of adult idiopathic inflammatory myopathy in patients with anti-Jo-1 and anti-signal recognition particle autoantibodies.","volume":"34","author":"Leff","year":"1991","journal-title":"Arthritis Rheum"},{"key":"R30-3-20210126","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3109\/s10165-008-0139-8","article-title":". Clinical and histopathological features of myopathies in Japanese patients with anti-SRP autoantibodies.","volume":"19","author":"Takada","year":"2009","journal-title":"Mod Rheumatol"},{"key":"R31-3-20210126","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1136\/jnnp.2008.169375","article-title":"Evaluation and treatment of inflammatory myopathies.","volume":"80","author":"Amato","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R32-3-20210126","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.clineuro.2011.12.055","article-title":". Unusual manifestations in two cases of necrotizing myopathy associated with SRP-antibodies.","volume":"114","author":"Hanisch","year":"2012","journal-title":"Clin Neurol Neurosurg"},{"key":"R33-3-20210126","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nmd.2007.01.004","article-title":". Paraneoplastic myopathy: response to intravenous immunoglobulin.","volume":"17","author":"Sampson","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"R34-3-20210126","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/art.30156","article-title":". Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy.","volume":"63","author":"Mammen","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R35-3-20210126","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s00415-003-1027-y","article-title":". Necrotising myopathy, an unusual presentation of a steroid-responsive myopathy.","volume":"250","author":"Bronner","year":"2003","journal-title":"J Neurol"},{"key":"R36-3-20210126","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.nmd.2006.10.007","article-title":". Progressive myopathy with up-regulation of MHC-I associated with statin therapy.","volume":"17","author":"Needham","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"R37-3-20210126","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/mus.21486","article-title":". Immune-mediated necrotizing myopathy associated with statins.","volume":"41","author":"Grable-Esposito","year":"2010","journal-title":"Muscle Nerve"},{"key":"R38-3-20210126","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/MD.0000000000000028","article-title":". Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin.","volume":"93","author":"Allenbach","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"R39-3-20210126","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1093\/brain\/119.6.1887","article-title":". Inclusion body myositis in HIV-1 and HTLV-1 infected patients.","volume":"119","author":"Cupler","year":"1996","journal-title":"Brain"},{"key":"R40-3-20210126","first-page":"651","article-title":". Polymyositis associated with HIV infection during immune restoration induced by highly active anti-retroviral therapy.","volume":"22","author":"Calza","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"R41-3-20210126","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/RHU.0b013e318268566c","article-title":". Dermatomyositis: a rare presentation of HIV seroconversion illness.","volume":"18","author":"Rajadhyaksha","year":"2012","journal-title":"J Clin Rheumatol"},{"key":"R42-3-20210126","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/mus.880100407","article-title":"Myopathy complicating the acquired immune deficiency syndrome.","volume":"10","author":"Stern","year":"1987","journal-title":"Muscle Nerve"},{"key":"R43-3-20210126","doi-asserted-by":"crossref","first-page":"842","DOI":"10.7326\/0003-4819-109-10-842","article-title":"Myopathy associated with human immunodeficiency virus (HIV) but not with zidovudine.","volume":"109","author":"Simpson","year":"1988","journal-title":"Ann Intern Med"},{"key":"R44-3-20210126","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ana.410240114","article-title":"Human immunodeficiency virus-associated myopathy: analysis of 11 patients.","volume":"24","author":"Simpson","year":"1988","journal-title":"Ann Neurol"},{"key":"R45-3-20210126","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1001\/archneur.1988.00520340038008","article-title":". The neuromuscular manifestations of human immunodeficiency virus infections.","volume":"45","author":"Lange","year":"1988","journal-title":"Arch Neurol"},{"key":"R46-3-20210126","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/mus.880130607","article-title":". Skeletal muscle pathology in AIDS: an autopsy study.","volume":"13","author":"Wrzolek","year":"1990","journal-title":"Muscle Nerve"},{"key":"R47-3-20210126","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0049-0172(98)80043-7","article-title":". Musculoskeletal manifestations and autoantibody profile in 90 hepatitis C virus infected Israeli patients.","volume":"28","author":"Buskila","year":"1998","journal-title":"Semin Arthritis Rheum"},{"key":"R48-3-20210126","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0248-8663(00)89230-9","article-title":". Association between polymyositis and hepatitis C infection. Treatment-related difficulties in French.","volume":"21","author":"Alric","year":"2000","journal-title":"Rev Med Interne"},{"key":"R49-3-20210126","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11910-011-0232-9","article-title":"Update on toxic myopathies.","volume":"12","author":"Mastaglia","year":"2012","journal-title":"Curr Neurol Neurosci Rep"},{"key":"R50-3-20210126","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.289.13.1681","article-title":"Statin-associated myopathy.","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"key":"R51-3-20210126","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/0049-0172(86)90019-3","article-title":"Clofibrate myopathy: a case report and a review of the literature.","volume":"15","author":"Rush","year":"1986","journal-title":"Semin Arthritis Rheum"},{"key":"R52-3-20210126","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.0954-6820.1969.tb07345.x","article-title":". Extensive muscle necrosis after long-term treatment with aminocaproic acid (EACA) in a case of hereditary periodic edema.","volume":"185","author":"Korsan-Bengtsen","year":"1969","journal-title":"Acta Med Scand"},{"key":"R53-3-20210126","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0272-0590(86)90273-3","article-title":"Evidence of necrosis in human intercostal muscle following inhalation of an organophosphate insecticide.","volume":"6","author":"Wecker","year":"1986","journal-title":"Fundam Appl Toxicol"},{"key":"R54-3-20210126","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrneurol.2011.63","article-title":"Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis.","volume":"7","author":"Mammen","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"R55-3-20210126","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.1990.03450010075034","article-title":"Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy.","volume":"264","author":"Pierce","year":"1990","journal-title":"JAMA"},{"key":"R56-3-20210126","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/s00296-011-2304-1","article-title":"Paraneoplastic necrotizing myopathy and dermatomyositis in a patient with rectosigmoid carcinoma.","volume":"33","author":"Samuels","year":"2013","journal-title":"Rheumatol Int"},{"key":"R57-3-20210126","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000308714","article-title":". Paraneoplastic necrotizing myopathy with a mild inflammatory component: a case report and review of the literature.","volume":"3","author":"Wegener","year":"2010","journal-title":"Case Rep Oncol"},{"key":"R58-3-20210126","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/mus.20693","article-title":". Myopathy associated with anti-signal recognition peptide antibodies: clinical heterogeneity contrasts with stereotyped histopathology.","volume":"35","author":"Dimitri","year":"2007","journal-title":"Muscle Nerve"},{"key":"R59-3-20210126","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/ana.410290512","article-title":". Eosinophilia myalgia syndrome: I. Immunocytochemical evidence for a T-cell-mediated immune effector response.","volume":"29","author":"Emslie-Smith","year":"1991","journal-title":"Ann Neurol"},{"key":"R60-3-20210126","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1212\/WNL.41.6.936","article-title":"Necrotizing myopathy with pipestem capillaries, microvascular deposition of the complement membrane attack complex (MAC), and minimal cellular infiltration.","volume":"41","author":"Emslie-Smith","year":"1991","journal-title":"Neurology"},{"key":"R61-3-20210126","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1136\/bmj.282.6279.1824","article-title":". Labetalol-induced toxic myopathy.","volume":"282","author":"Teicher","year":"1981","journal-title":"Br Med J (Clin Res Ed)"},{"key":"R62-3-20210126","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.ajpath.2012.08.033","article-title":". Immune-mediated necrotizing myopathy is characterized by a specific Th1-M1 polarized immune profile.","volume":"181","author":"Preusse","year":"2012","journal-title":"Am J Pathol"},{"key":"R63-3-20210126","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1002\/art.34673","article-title":". Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.","volume":"64","author":"Werner","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R64-3-20210126","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1752-1947-3-95","article-title":". Paraneoplastic necrotizing myopathy in a woman with breast cancer: a case report.","volume":"3","author":"Silvestre","year":"2009","journal-title":"J Med Case Rep"},{"key":"R65-3-20210126","first-page":"556","article-title":". Paraneoplastic necrotizing myopathy presenting as severe muscle weakness in a patient with small-cell lung cancer: successful response to chemoradiation therapy.","volume":"9","author":"Vu","year":"2011","journal-title":"Clin Adv Hematol Oncol"},{"key":"R66-3-20210126","first-page":"437","article-title":"Christodoulou C, et al..","volume":"93","author":"Galani","year":"2009","journal-title":"Can cetuximab affect paraneoplastic myopathy J Neurooncol"},{"key":"R67-3-20210126","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/art.11002","article-title":". Human immunodeficiency virus-associated polymyositis: a longitudinal study of outcome.","volume":"49","author":"Johnson","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R68-3-20210126","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/j.lpm.2011.02.002","article-title":"Inflammatory or necrotizing myopathies, myositides and other acquired myopathies, new insight in 2011.","volume":"40","author":"Benveniste","year":"2011","journal-title":"Presse Med"}],"container-title":["Journal of Clinical Neuromuscular Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CND.0000000000000065","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,6]],"date-time":"2023-08-06T09:46:26Z","timestamp":1691315186000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00131402-201503000-00003"}},"subtitle":["An Update"],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/cnd.0000000000000065","relation":{},"ISSN":["1522-0443"],"issn-type":[{"value":"1522-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]}}}